
Approval: 2015 -RECENT MAJOR CHANGES- Dosage and Administration, Recommended Dose (2.1) 10/2021 Dosage and Administration, Preparation (2. PRAXBIND® (idarucizumab) injection, for intravenous use Initial U.S. Reprinted with permission by First Databank, Inc. See full prescribing information for PRAXBIND.

WAC = wholesaler acquisition cost or manufacturer’s published price to wholesalers WAC represents a published catalogue or list price and may not represent an actual transactional price.

Given the high cost of idarucizumab, hospitals in geographic proximity. Dabigatran etexilate (Pradaxa) - a new oral anticoagulant. Idarucizumab costs 3,662 for a single treatment (i.e., two infusions). Idarucizumab, an antidote for dabigatran, was recently approved for use in Canada.
